News and blog posts
15
Jan 2020
Dutch Healthcare Authority (NZa) has released key features of the DRG package for 2021, including complex chronic lung failure, stem cell transplant care, indexation of DRG tariffs, and position about reimbursment of MammaPrint test.
Read more
14
Jan 2020
In December 2019, the National Institute for Health and Care Excellence (NICE) published one new interventional procedure guidance (for balloon dilation for chronic eustachian tube dysfunction), one new medical technologies guidance (for gammaCore for cluster headache), and five new MedTech innovation briefings (for Optowire for measuring fractional flow reserve, eXroid for internal hemorrhoids, and others).
Read more
13
Jan 2020
In mid-December 2019, the Swiss Federal Department for Home Affairs (FDHA) has decided that two new autologous cell therapies (CAR-T therapies) for the treatment of leukemia and lymphoma will be reimbursed by compulsory health care insurance.
Read more
11
Jan 2020
On the week of 6th of January, MTRC published several posts related to the process of DRG change in England, list of technologies with different levels of added value (ASA) in France, countries offering access to hospital procedure volume information, improvements with glaucoma minimally invasive surgery reimbursement in England, the role of DRG in Scandinavia, and list of countries actively using DRG system for case-by-case reimbursement. Follow us on Instagram on mtrc.market.access
Read more
07
Jan 2020
In mid-November 2019, the report of the project OTCA20, titled “Prophylactic or therapeutic use of endoanchoring systems in endovascular aortic aneurysm repair (EVAR/TEVAR)” was published on the website of the European Network for HTA (EUnetHTA).
Read more
06
Jan 2020
At the start of the organized program for the early detection of cervical cancer on January 1, 2020, several new services will be added to the EBM (Einheitlicher Bewertungsmaβstab, German Uniform Evaluation Standard).
Read more
03
Jan 2020
In early November 2019, the report of the project OTCA18, titled “Regional hyperthermia for high-risk soft tissue sarcoma treatment” was published on the website of the European Network for HTA (EUnetHTA).
Read more
30
Dec 2019
On November 7, 2019, the Nomenclature was updated. The update brought changes in chapter V of Nomenclature, regarding the creation of new codes and modification of existing codes.
Read more
27
Dec 2019
On the 20th of November, the Danish Health Authority (Sundhedsstyrelsen) has published a national clinical guideline for the oxygen therapy of acutely ill adult patients.
Read more
26
Dec 2019
We will share selective news, opinions, commentary, and analysis on the topic of European market access for medical technologies on Instagram. We are planning to develop specific content for Instagram, not fully matching the content of our websites. You can find our account at mtrc.market.access
Read more
26
Dec 2019
In late November 2019, the network of European HTA agencies, EUnetHTA, announced the final plan of the project OTCA23 “Biodegradable rectum spacers to reduce toxicity for prostate cancer.”
Read more
25
Dec 2019
In December 2019, the Swiss Medical Tariff Commission (MTK/CTM) has published their recommendations regarding the knee Autologous Chondrocyte Implantation (ACI). The CTM recommends covering the costs of the implant for knee ACI until the end of 2024.
Read more